Literature DB >> 12686591

Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation.

Jalal Ahmed-Choudhury1, Clare L Russell, Satinder Randhawa, Lawrence S Young, David H Adams, Simon C Afford, Jalal Ahmed Choudhury.   

Abstract

CD40, a tumor necrosis factor receptor superfamily member, is up-regulated on intraheptatic endothelial cells (IHEC) and epithelial cells during inflammatory liver disease, and there is evidence that the functional outcome of CD40 ligation differs between cell types. Ligation of CD40 on cholangiocytes or hepatocytes results in induction of Fas-mediated apoptosis, whereas ligation of IHEC CD40 leads to enhanced chemokine secretion and adhesion molecule expression. We now report that differential activation of two transcription factors, nuclear factor-kappaB (NF-kappaB) and activator protein-1 (AP-1), in primary human hepatocytes or IHEC, is associated with and may explain, in part, the different responses of these cell types to CD40 ligation. CD40 ligation induced a rise in NF-kappaB activity in hepatocytes,which peaked at 2 h and returned to baseline by 24 h; however, IHEC CD40 ligation resulted in a sustained up-regulation of NF-kappaB (>24 h). In hepatocytes, CD40 ligation led to sustained up-regulation of AP-1 activity >24 h associated with increased protein levels of RelA (p65), c-Jun, and c-Fos, whereas no induction of AP-1 activity was observed in IHECs. Analysis of mitogen-activated protein kinase phosphorylation (phospho-extracellular signal-regulated kinase 1/2 and phospho-c-Jun NH(2)-terminal kinase 1/2) and expression of inhibitor kappaBalpha were entirely consistent, and thus confirmed the profiles of NF-kappaB and AP-1 signaling and the effects of the selective inhibitors assessed using electrophoretic mobility shift assay or Western immunoblotting. CD40 ligation resulted in induction of apoptosis in hepatocytes after 24 h, but on IHECs, CD40 ligation resulted in proliferation. Inhibition of (CD40-mediated) NF-kappaB activation prevented IHEC proliferation and led to induction of apoptosis. Selective extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase inhibitors reduced levels of apoptosis in (CD40-stimulated) hepatocytes by approximately 50%. We conclude that differential activation of these two transcription factors in response to CD40 ligation is associated with differences in cell fate. Transient activation of NF-kappaB and sustained AP-1 activation is associated with apoptosis in hepatocytes, whereas prolonged NF-kappaB activation and a lack of AP-1 activation in IHECs result in proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686591      PMCID: PMC153104          DOI: 10.1091/mbc.e02-07-0378

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  55 in total

1.  NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.

Authors:  Y Iimuro; T Nishiura; C Hellerbrand; K E Behrns; R Schoonhoven; J W Grisham; D A Brenner
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  Transcriptional regulation of the human FasL promoter-enhancer region.

Authors:  C J Holtz-Heppelmann; A Algeciras; A D Badley; C V Paya
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

3.  Regulation of IkappaB beta in WEHI 231 mature B cells.

Authors:  R J Phillips; S Ghosh
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells.

Authors:  S H Hanissian; R S Geha
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

5.  Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis.

Authors:  K Harada; S Ozaki; M E Gershwin; Y Nakanuma
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

6.  CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.

Authors:  A G Eliopoulos; C W Dawson; G Mosialos; J E Floettmann; M Rowe; R J Armitage; J Dawson; J M Zapata; D J Kerr; M J Wakelam; J C Reed; E Kieff; L S Young
Journal:  Oncogene       Date:  1996-11-21       Impact factor: 9.867

7.  Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB.

Authors:  S Kasibhatla; L Genestier; D R Green
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

8.  Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death.

Authors:  H Le-Niculescu; E Bonfoco; Y Kasuya; F X Claret; D R Green; M Karin
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 9.  CD40 and epithelial cells: across the great divide.

Authors:  L S Young; A G Eliopoulos; N J Gallagher; C W Dawson
Journal:  Immunol Today       Date:  1998-11

10.  CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection.

Authors:  S C Afford; S Randhawa; A G Eliopoulos; S G Hubscher; L S Young; D H Adams
Journal:  J Exp Med       Date:  1999-01-18       Impact factor: 14.307

View more
  15 in total

Review 1.  The role of chemokines in the recruitment of lymphocytes to the liver.

Authors:  Ye H Oo; Shishir Shetty; David H Adams
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

2.  Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice.

Authors:  Jiabin Yan; Zuliang Jie; Lifei Hou; Joao L Wanderley; Lynn Soong; Shalini Gupta; Suimin Qiu; Tehsheng Chan; Jiaren Sun
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

Review 3.  Immune Cell Trafficking to the Liver.

Authors:  Sulemon Chaudhry; Jean Emond; Adam Griesemer
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

4.  Chronic prenatal stress epigenetically modifies spinal cord BDNF expression to induce sex-specific visceral hypersensitivity in offspring.

Authors:  J H Winston; Q Li; S K Sarna
Journal:  Neurogastroenterol Motil       Date:  2014-03-04       Impact factor: 3.598

5.  The atheroprotective properties of Hsp70: a role for Hsp70-endothelial interactions?

Authors:  A Graham Pockley; Stuart K Calderwood; Gabriele Multhoff
Journal:  Cell Stress Chaperones       Date:  2009-04-09       Impact factor: 3.667

6.  Genes Induced by Reovirus Infection Have a Distinct Modular Cis-Regulatory Architecture.

Authors:  R Lapadat; R L Debiasi; G L Johnson; K L Tyler; I Shah
Journal:  Curr Genomics       Date:  2005       Impact factor: 2.236

Review 7.  The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future.

Authors:  Eric M Jacobson; Yaron Tomer
Journal:  J Autoimmun       Date:  2007-03-21       Impact factor: 7.094

8.  Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo.

Authors:  S Finotto; J Siebler; M Hausding; M Schipp; S Wirtz; S Klein; M Protschka; A Doganci; H A Lehr; C Trautwein; R Khosravi-Far; D Strand; A Lohse; P R Galle; M Blessing; M F Neurath; R Khosravi-Fahr
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

Review 9.  Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo.

Authors:  P F Lalor; W K Lai; S M Curbishley; S Shetty; D H Adams
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

10.  Activation of CD40 with platelet derived CD154 promotes reactive oxygen species dependent death of human hepatocytes during hypoxia and reoxygenation.

Authors:  Ricky H Bhogal; Christopher J Weston; Stuart M Curbishley; David H Adams; Simon C Afford
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.